Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial.
暂无分享,去创建一个
Simak Ali | S. Shousha | D. Vigushin | H. Sinnett | J. Mansi | D. Hadjiminas | A. Polychronis | R. Coombes | H. Singhal | M. Slade | N. Barrett | D. Peston | Jie Jiang | Dharsha Shivapatham | Ken Morrison | E. Beresford